The rhoptries are key secretory organelles from apicomplexan parasites that contain proteins involved in invasion and modulation of the host cell. Some rhoptry proteins are restricted to the posterior bulb (ROPs) and others to the anterior neck (RONs). As many rhoptry proteins have been shown to be key players in Toxoplasma invasion and virulence, it is important to identify, understand and characterise the biological function of the components of the rhoptries. In this report, we identified putative novel rhoptry genes by identifying Toxoplasma genes with similar cyclical expression profiles as known rhoptry protein encoding genes. Using this approach we identified two new rhoptry bulb (ROP47 and ROP48) and one new rhoptry neck protein (RON12). ROP47 is secreted and traffics to the host cell nucleus, RON12 was not detected at the moving junction during invasion. Deletion of ROP47 or ROP48 in a type II strain did not show major influence in in vitro growth or virulence in mice.
Identification of three novel

Introduction
Toxoplasma gondii is a highly successful parasite infecting approximately 30% of people worldwide and is the second largest cause of death due to foodborne illness in the United States (Scallan et al., 2011) . Toxoplasmosis can be fatal in the unborn fetus and in immunosuppressed individuals if the disease is not recognised and treated early, in contrast to immunocompetent patients in whom it is mainly self-limited (Montoya and Liesenfeld, 2004; Scallan et al., 2011) .
Toxoplasma resides within a non-fusogenic parasitophorous vacuole and has three apical secretory organelles: the dense granules, micronemes and rhoptries. Rhoptries are club-shaped organelles divided into two distinct compartments, the posterior bulb and the more anterior duct (neck) through which rhoptry proteins are secreted. Proteins derived from the rhoptry secretory organelles are crucial for the invasion and survival of apicomplexan parasites within host cells and thus rhoptry protein targeting is a vital process for Toxoplasma. Some rhoptry proteins are restricted to the bulb (ROPs) and others to the neck (RONs). The role of rhoptries in the invasion process, virulence and/or host cell modulation has been well documented, although the molecular mechanisms remain only partially understood. RONs 2, 4, 5 and 8 have been shown to be involved in parasite invasion of the host cell (Besteiro et al., 2009; Straub et al., 2009 ); ROP16 activates the transcription factors STAT3 and STAT6 (Saeij et al., 2007; Yamamoto et al., 2009; Ong et al., 2010) ; ROP38 downregulates Mitogen Activated Protein Kinase (MAPK) pathway activation (Peixoto et al., 2010) ; and ROP5 and ROP18 act jointly to block immunity-related GTPase (IRG) mediated clearance of the parasite by the host cell (Behnke et al., 2012; Fleckenstein et al., 2012; Niedelman et al., 2012) . Once rhoptry proteins are secreted into the host cell cytosol they traffic to distinct cellular destinations. For example, ROP16 and the rhoptry protein phosphatase 2 C (PP2C-hn) carry a nuclear localisation signal (NLS), which mediates their trafficking to the host nucleus (Gilbert et al., 2007; Saeij et al., 2007) , ROP5 and ROP18, following secretion into the host cell, traffic back to the outside of the parasitophorous membrane vacuole (PVM) via an arginine-rich amphipathic helix domain that is essential for this localisation (Reese and Boothroyd, 2009; Fentress et al., 2012) . Other rhoptry proteins, such as Toxofilin, remain in the host cell cytosol upon secretion (Lodoen et al., 2010) .
Rhoptry proteins contain a classic eukaryotic signal peptide for entrance into the secretory pathway and are trafficked from the endoplasmic reticulum through the Golgi by a conserved pathway before being packaged into the apically located secretory organelles (Sadak et al., 1988; Bradley and Boothroyd, 1999; Bradley et al., 2004; Carey et al., 2004; Hajj et al., 2006b Hajj et al., , 2007 Turetzky et al., 2010) . N-terminal pro-domains have been implicated in rhoptry protein sorting and indeed several rhoptry proteins exhibit N-terminal processing. However, the failure to remove the pro-domain does not seem to disrupt targeting (Bradley et al., 2002; Miller et al., 2003; Turetzky et al., 2010) . Other rhoptry proteins do not appear to be processed and the mechanism by which they are targeted to the rhoptries is unknown. Additionally, any soluble protein recombinantly fused to a signal peptide is delivered to the dense granules by default (Joiner and Roos, 2002) . Therefore, motifs that mediate trafficking of proteins to the rhoptry organelles are insufficiently defined, or insufficiently specific, to allow genome-wide identification of rhoptry proteins.
Proteomic and genomic approaches have been widely used to identify the contents of the rhoptries of apicomplexan parasites (Hoppe et al., 2000; Bradley et al., 2005; Peixoto et al., 2010; Marugán-Hernández et al., 2011; Reid et al., 2012; Oakes et al., 2013) . A proteomic study of Toxoplasma rhoptry contents led to the identification of 38 rhoptry proteins (Bradley et al., 2005) . Twenty of these proteins were shown to localise to the rhoptry organelles, 11 to the rhoptry bulb and nine to the rhoptry neck (Bradley et al., 2005; Taylor et al., 2006; Gilbert et al., 2007; Proellocks et al., 2009; Straub et al., 2009; Peixoto et al., 2010; Lamarque et al., 2012) . As expected, several previously known rhoptry proteins were readily detected in this proteomic analysis. However, TgNHE2 and TgSUB2, previously characterised as rhoptry proteins, were missed. The absence of these known rhoptry proteins is likely due to limitations of the technique, such as size cut-off or low amounts of protein.
Because several rhoptry proteins, such as the aforementioned ROP5, ROP16, ROP18 and ROP38, contain kinase-like domains (Hajj et al., 2006a; Peixoto et al., 2010) , another study exploited a phylogenomic approach to characterise the Toxoplasma kinome, defining a 44-member family of kinase-like rhoptry proteins based on sequence similarities, including all previously reported kinase-like rhoptry proteins (Peixoto et al., 2010) . To evaluate the accuracy of these predictions, nine of the identified kinase-like rhoptry proteins were confirmed to localise to the rhoptries, whereas two (ROP21 and ROP22) did not but were still annotated as rhoptry proteins. Surprisingly, the overlap between these two studies is relatively small, with only 11 genes found in common, which emphasizes the complementarity of different methodologies and the likelihood that there are still rhoptry proteins yet to be identified.
Previous characterisation of the cell cycle transcriptome of Toxoplasma covering 12 h post-synchronisation and nearly two tachyzoite replication cycles showed that the mRNA levels of genes encoding for proteins secreted from the rhoptry organelles display a cyclical expression profile, reaching peak levels in late S phase/ early mitosis followed by a rapid and dramatic decline of these transcripts in early G1, before peaking again in the next S phase . Inner membrane complex (IMC) mRNAs presented a very similar cyclical expression profile. Microneme mRNAs were offset by 1-2 h from rhoptry mRNAs and defined a distinct temporal class. By contrast, dense granule mRNAs largely were not regulated in the tachyzoite cell cycle.
Here we combined in silico and in vivo methods to identify novel rhoptry proteins likely to be involved in parasite modulation of host cells and found two novel rhoptry bulb proteins and one novel rhoptry neck protein.
Materials and methods
Parasites and cell lines
Parasites were maintained in vitro by serial passage on monolayers of human foreskin fibroblasts (HFFs) at 37°C in 5% CO 2 . HFFs were grown in DMEM supplemented with 10% FBS. C57BL6/J mouse embryonic fibroblasts (MEFs) were a gift from A. Sinai (University of Kentucky College of Medicine, Lexington, KY, USA) and were grown in HFF media supplemented with 10 mM HEPES, 1 mM sodium pyruvate and 1Â non-essential amino acids.
Identification of candidate genes
For identification of new rhoptry protein coding genes, cell cycle transcriptome data of the T. gondii during synchronised growth in human foreskin fibroblasts (HFFs) deposited at Gene Expression Omnibus (GEO) with accession number GSE19092 were used . The data were normalised using Robust Multi Array (RMA) algorithm using Affymetrix Expression Console Software version 1.3.1, and all background values less than 6.5 were set to 6.5. Genes with an expression value of less than 6.5 in 12 or more samples where removed from the analysis. K-means clustering of each duplicated sample (time-point) was performed using the default distance metric (Pearson correlation) and a maximum number of 50, 45, 40, 35, 30, 25, 20, 12 and 10 clusters in Multiple Array Viewer 4.6. The cluster with the largest number of previously annotated rhoptry proteins was chosen for further analysis. The candidate genes were chosen using the following criteria: (i) contained a predicted signal peptide, (ii) had unannotated function and (iii) unknown subcellular localisation.
Gene tagging
Genomic sequences were obtained from the ToxoDB database (Version 8.0, ToxoDB.org) (Kissinger et al., 2003) . For endogenous gene tagging (Huynh and Carruthers, 2009) , primers were designed to amplify 1-3 kb of the predicted 3 0 ends of genes. For heterologous expression of ROP47, the coding regions of TGME49_261740, together with putative promoter ($1500 bp upstream of ATG start codon) were amplified by PCR. All forward primers contained the 5 0 -CACC-3 0 sequence required to perform directional TOPO cloning in pENTR/D-TOPO (Invitrogen, USA) and all reverse primers contained the hemagglutinin (HA) tag sequence followed by a stop codon (Table 1) . HA-tagged sequences were cloned in vector pTKOatt by Gateway Recombination Cloning Technology (Invitrogen, USA). For endogenous gene tagging, the resulting vectors were linearised using a restriction enzyme with a unique restriction site within the cloned fragment. Linearised vector was transfected into RHDhxgprtDku80 (a gift from V. Carruthers, University of Michigan, Ann Arbor, MI, USA) parasites by electroporation. For heterologous expression of ROP47, vector was not linearised and was transfected into RHDhxgprt. Electroporation was done in a 2 mm cuvette (Bio-Rad Laboratories, USA) with 2 mM ATP (MP Biomedicals, USA) and 5 mM glutathione (EMD, Germany) in a Gene Pulser Xcell (Bio-Rad Laboratories), with the following settings: 25 lFD, 1.25 kV, 1X. Stable integrants were selected in media with 50 lg/ml of mycophenolic acid (Axxora, USA) and 50 lg/ml of xanthine (Alfa Aesar, USA) and cloned by limiting dilution. The correct tagging of each gene was confirmed by PCR, using a primer upstream of the plasmid integration site and a primer specific for the HA tag and/or by immunofluorescence (IF) analysis.
IF analysis
Parasites were allowed to invade cells on coverslips and incubated for 16-24 h. The cells were then fixed with 3% (vol/vol) formaldehyde in PBS for 20 min at room temperature and blocked in PBS with 3% (wt/vol) BSA and 5% (vol/vol) goat serum. Coverslips were incubated with primary antibody for 1 h at room temperature or overnight at 4°C, and fluorescent secondary antibodies and Hoechst dye were used for antigen and DNA visualisation, respectively. Coverslips were mounted on a glass slide with Vectashield (Vector Laboratories, USA), and photographs were taken using NIS-Elements software (Nikon, Japan) and a digital camera (Cool-SNAP EZ; Roper Industries, USA) connected to an inverted fluorescence microscope (model eclipse Ti-S; Nikon). To determine seroconversion, peripheral blood serum was used as a primary TTACGCGTAGTCCGGGACGTCGTACGGGTAGAGTTCAGCGAAAGCACCTGC  TGME49_210370  CACCACAGCCCGTTACGTCTTGCGAC  TTACGCGTAGTCCGGGACGTCGTACGGGTAAACGGAGGGAAGAAACGGGG  TGME49_218270  CACCGGCTGGAGATTTTTCCCCGGAACT  TTACGCGTAGTCCGGGACGTCGTACGGGTAAGCCGGACTTGCAGAAGGCAC  TGME49_225160  CACCCCATGCTTCTGTTCGCAGAAAT  TTACGCGTAGTCCGGGACGTCGTACGGGTATGAATCCTTGAAACTGCGAATC  TGME49_232020  CACCTGGCTCTCCAGCCGCGGCGATT  TTACGCGTAGTCCGGGACGTCGTACGGGTATCGTCGCCGGCGCCTTCCGC  TGME49_237180  CACCAGAAACCGCTGCTGAGGAATGG  TTACGCGTAGTCCGGGACGTCGTACGGGTACATAAGAAATTTTATTTTATGGAGGCG  TGME49_258360  CACCGCGGTGTTCGTCAGGATCTGCT  TTACGCGTAGTCCGGGACGTCGTACGGGTACCCGTTAAGATGCGCAACGAC  TGME49_261740 CACCACAAAACGGGGAGCA TTACGCGTAGTCCGGGACGTCGTACGGGTACGGTCTTTTTCCACCTTTCACACG Primers used for gene knock-out antibody. For co-localisation experiments, GFP-expressing parasites were fixed with methanol or 3% (vol/vol) formaldehyde. For moving junction staining, this standard IF protocol was modified slightly. Parasites were added to HFFs on coverslips, spun down to bring them into contact with host cells, and allowed to attach to and invade host cells for 5 min at 37°C. Unattached parasites were washed off with PBS, and cells were fixed with 3% (vol/vol) formaldehyde in PBS for 20 min at room temperature, blocked in PBS with 5% (vol/vol) FBS and 5% (vol/vol) normal goat serum for 1-2 h at room temperature, and permeabilized by incubation in PBS with 0.2% (wt/vol) saponin at 37°C for 20 min.
Antibodies
Recombinant ROP47 peptide antigen was generated by PCR amplification of sequences immediately downstream of the predicted ROP47 signal peptide and immediately upstream of the ROP47 stop codon from PruDhxgprt genomic DNA. The amplicon was cloned in frame into pET102/D-TOPO (Invitrogen), creating a Thioredoxin-ROP47-V5-His6 construct. This protein was expressed in BL21 Star (Invitrogen) cells and purified on a Ni-NTA column (Invitrogen) eluted with 250 mM imidazole and dialyzed under native conditions according to the manufacturer's directions. Rabbit polyclonal antibodies (Covance, USA) were raised against the purified peptide antigen. Antibodies were affinity purified from the ROP47 antiserum with Affi-Gel 10 resin (Bio-Rad) covalently coupled to the antigen peptide and eluted with 100 mM Glycine, pH 2.5, then immediately neutralized with 1 M Tris pH 8.0. The eluate was subsequently incubated with Affi-Gel 10 resin covalently coupled to a Thioredoxin-V5-His6 peptide that was expressed and purified as above to remove antibodies in the serum reacting against thioredoxin and the epitope tags. The flow-through was collected, tested for specificity and used for immunogenic assays.
Antibodies against HA (Roche), Toxoplasma surface antigen (SAG)-1 (DG52, (Burg et al., 1988) ), Toxoplasma rhoptry protein ROP1 (Tg49; (Ossorio et al., 1992) ), Toxoplasma dense granule protein GRA7 (Dunn et al., 2008) , Toxoplasma rhoptry neck protein RON4 (generously provided by P. Bradley, University of California, Los Angeles, CA, USA), Toxoplasma inner membrane complex proteins IMC1 and MLP1 (generously provided by M.J. Gubbels, Boston College, Boston, MA, USA) and mouse TGTP (A-20; Santa Cruz Biotechnology, USA) were used in the IF assay. IF secondary antibodies were coupled with Alexa Fluor 488 or Alexa Fluor 594 (Invitrogen).
Western blot
Parasites were syringe lysed from infected HFFs with lysis buffer, boiled for 5 min and subjected to 10% SDS-PAGE. Proteins were transferred to a polyvinylidene difluoride membrane, which was blocked in PBS/0.1% Tween-20/5% non-fat dry milk and incubated with primary and secondary antibodies. The blot was incubated with a luminal-based substrate (Immun-Star WesternC; Bio-Rad Laboratories) and chemiluminescence was detected using a charge-coupled device camera (Chemidoc XRS; Bio-Rad Laboratories). The bands were visualised using Quantity One 1-D analysis software.
Generation of gene knockouts (KOs)
The 5 0 and 3 0 flanking regions of the genes to be knocked out were cloned in pTKO2 (Rosowski et al., 2011) around the hypoxanthine-xanthine-guanine ribosyl transferase (HXGPRT) selectable marker using Multisite Gateway Pro 3-Fragment Recombination (Invitrogen). Flanking regions (5 0 and 3 0 ) of TGME49_201860, TGME49_218270 and TGME49_261740 were cloned from type II genomic DNA. Primers contained att recombination sites (denoted in primer sequence with italics, Table 1 ) and amplified %2 kb upstream of the start codon and downstream of the stop codon. These flanking regions were then cloned around the HXGPRT selectable marker flanked by 5 0 and 3 0 untranslated region (UTRs) from dihydrofolate reductase (DHFR), as previously described (Rosowski et al., 2011) . Before transfection, the KO vector was linearised. PruDhxgprtDku80 (a gift from D. Bzik, Dartmouth Medical School, Lebanon, NH, USA) parasites were transfected with the KO construct by electroporation, and stable integrants were selected and cloned by limiting dilution, as described in Section 2.3. PCR with a forward primer upstream of the 5 0 flanking region (P1) and a reverse primer within the HXGPRT cassette (P2) confirmed the disruption in the desired loci (Supplementary Fig. S1A ). Additionally, PCR was performed to confirm the inability to amplify the target genes (P3 and P4) (Supplementary Fig. S1A ).
Plaque assays
For the plaque assays, 100-500 parasites per well were added to monolayers of MEFs seeded the day before and either previously stimulated with 1000 U/mL of mouse IFNc or left unstimulated for 24 h before infection in a 24 well plate in MEF media. Infections were then incubated for 5 days at 37°C and the number of plaques was counted using a microscope.
Animal infections
Six to 10 week old female C57BL/6 J mice (The Jackson Laboratory, USA) were used in all experiments. For i.p. infection, tachyzoites were grown in vitro and extracted from host cells by passage through a 30-gauge needle, washed twice in PBS and quantified with a hemocytometer. Parasites were diluted in PBS and mice were inoculated i.p. with 500 tachyzoites of each strain (in 100 lL) using a 28-gauge needle. For oral infection, brain homogenate of chronically infected mice was stained with dolichos biflorus-FITC (Vector Laboratories) and cysts were enumerated by microscopy. The mice were orally gavaged with 1000 cysts. All of the animals were monitored daily and weighed three times per week. Peripheral blood serum was collected on days 7 and 30 of the experiment and the levels of IFNc were determined using commercially available ELISA kits, according to the manufacturer's protocol (eBioscience, USA). The Massachusetts Institute for Technology, USA, Committee on Animal Care approved all protocols. All mice were maintained under specific pathogen-free conditions, in accordance with institutional and federal regulations.
Results and discussion
Identification of novel rhoptry proteins
Previous characterisation of the Toxoplasma cell cycle transcriptome showed that the mRNA levels of rhoptry encoding genes display the same cyclical expression profile . We hypothesised that unidentified rhoptry encoding genes would show a similar expression profile. Genes were identified that showed the same expression pattern as established rhoptry encoding genes by performing K-means clustering of 13 duplicate samples spanning 12 h post-thymidine release into the tachyzoite cell cycle. The cluster with the largest number of previously annotated rhoptry protein encoding genes (67 out of 75 annotated rhoptry encoding genes were expressed above background and were present on the Toxoplasma array; Supplementary Table S1) was chosen for further analysis (Table 2, Supplementary Fig. S2 ). This cluster contained 190 unique genes, of which 45 encoded Table 2 Toxoplasma genes in the rhoptry cluster. (See below-mentioned references for further information.)
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Genes highlighted in grey were further characterised in this study.
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proteins annotated as rhoptries (out of 67 possible genes) and four encoded IMC proteins. Thirty-one out of these 45 have been previously confirmed to localise to the rhoptry organelles.
The Toxoplasma genome is predicted to encode 8127 genes, 1920 of which have a signal peptide (23.4%). Our analysis imposed no explicit selection for genes coding for proteins with signal peptide sequences; however, the resulting list is enriched (65 genes with a predicted signal peptide out of 190, P = 0.0003, Hypergeometric distribution) in signal-peptide-containing proteins (34%).
Interestingly, 22 out of the 75 tachyzoite rhoptry proteins encoding genes never clustered with the remainder of the rhoptries (Supplementary Table S1 ). Two of these genes (RON2L1 and BRP1 (Schwarz et al., 2005; Fritz et al., 2012) ) encode bradyzoiteor sporozoite-specific rhoptry proteins and six encode confirmed tachyzoite rhoptries (ROP9, ROP38, ROP39, TgARO, Toxolysin 1 and Subtilisin 2). According to the cell cycle expression data , ROP9, ROP38 and ROP39 do not display an obvious cyclical expression profile. In addition, ROP9 was shown to be secreted with micronemal proteins, in a calcium-dependent manner (Kawase et al., 2007) . The cellular localisation of the proteins encoded by the other 14 genes annotated as rhoptry protein genes (Supplementary Table S1 ) was never confirmed by IF and it is therefore possible that these are not localised to the rhoptries.
These results underscore the relevance of our approach and strongly suggest that our rhoptry protein cluster might contain many of the remainder of the unidentified rhoptry protein-encoding genes of tachyzoites. To identify new putative rhoptry protein encoding genes that could modulate host cell functions, we chose eight genes that encoded a protein with a predicted signal peptide, unannotated function and unknown subcellular localisation from Supplementary Fig. S2 ). Shown are eight genes that displayed an expression profile signature similar to the rhoptry pattern and that were chosen for further analysis. The expression profile of ROP1 is also shown. within our rhoptry cluster. The eight candidate genes are described in Table 2 , highlighted in grey, and all display the cyclic expression profile described above (Fig. 1) .
To determine the localisation of the candidate gene products within the parasite, we genetically engineered Toxoplasma strains expressing an HA-tagged version of the candidate genes at their endogenous loci. We were unable to endogenously tag TGME49_261740 and therefore determined its localisation by heterologous expression of a C-terminal HA-tagged copy of the candidate gene, including at least 1500 bp of the putative endogenous promoter. The correct tagging of each endogenously tagged gene was confirmed by PCR ( Supplementary Fig. S3 ). IF analysis was performed on HFFs infected with each of the HA-tagged parasites. The staining pattern of four out of eight candidate gene products was unlike that of the secretory organelles and appeared to label the whole parasite ( Supplementary Fig. S4 ). The genes whose labeling appeared consistent with that of the secretory organelles were TGME49_201860, TGME49_218270, TGME49_232020 and TGME49_261740 ( Fig. 2A) . Some characteristics of the proteins encoded by these genes are described in Table 3 .
The product of TGME49_201860-HA appears to have a punctate distribution, present at both the posterior and the apical end of the parasite ( Fig. 2A) . TGME49_218270-HA seems to label the rhoptry bulb. We were unable to detect these two proteins using an anti-HA Western blot, and therefore do not know whether they undergo post-transcriptional processing.
TGME49_232020-HA localises to the apical pole of the parasite, a labeling consistent with the rhoptry neck ( Fig. 2A) . This gene is predicted to encode a protein with no signal peptide in type II parasites. However, as first exon prediction is notoriously difficult, in type I and type III parasites, this protein is predicted have a signal peptide. Moreover, TGME49_232020 encodes a protein with a predicted molecular weight of 135 kDa. However, Western blot analysis of the TGME49_232020-HA strain detected a band of approximately 40 kDa, instead of the predicted 135 kDa (Supplementary Fig. S5 ). Indeed, several rhoptry proteins exhibit N-terminal processing and that is also probably the case for TGME49_232020. The rhoptry subtilisin TgSUB2 recognises and cleaves after the consensus sequence SUXE (Miller et al., 2003) . There is a putative SUB2 cleavage site (SPQE) between amino acids 968 and 971 of TGME49_232020. Cleavage at this site would generate a $32 kDa tagged product, which could be consistent with the band observed. Longer exposures did not reveal a 135 kDa pro-protein, suggesting that the half-life of the pro-protein is very short.
TGME49_261740-HA appears to label the entire rhoptry organelle ( Fig. 2A) . Interestingly, TGME49_261740 is in the top five of the most highly expressed genes across the Toxoplasma cell cycle and is one of the most polymorphic Toxoplasma genes (Minot et al., 2012) . Anti-HA Western blotting of this protein detected a band of approximately 15 kDa, consistent with the predicted size of 14 kDa (Supplementary Fig. S1B ).
These four proteins are conserved between Toxoplasma and Neospora (Table 3) , but protein BLAST analysis did not reveal the presence of close (30% or more protein identity) homologues in other apicomplexans. Additionally, no known conserved domains were detected, giving no indication about the potential function of these proteins.
TGME49_218270, TGME49_232020 and TGME49_261740 encode new rhoptry proteins
To further confirm the localisation of TGME49_201860, TGME49_218270, TGME49_232020 and TGME49_261740 within the parasite, we performed co-staining of each protein with a rhoptry bulb marker, ROP1, on intracellular parasites ( Fig. 2A ). TGME49_218270-HA shows a perfect co-localisation with ROP1.
TGME49_201860-HA does not overlap with this rhoptry marker. To further investigate the cellular localisation of this protein, we co-stained the TGME49_201860-HA expressing parasites with dense granule (GRA7) and inner membrane complex (IMC1 and MIP1-like protein-1 (MLP1)) markers (Fig. 2B) . TGME49_201860-HA appears to partially overlap with GRA7. In addition, while it does not co-localise with IMC1, it co-localises with MLP1, a protein that is present at the apical cap and basal complex of mature as well as budding daughter parasites (Gubbels, personal communication).
TGME49_232020-HA showed labeling of the apical pole anterior to the rhoptry bulb protein ROP1, as well as co-localisation with RON4 staining (Fig. 2C) , confirming rhoptry neck localisation in intracellular parasites. Interestingly, TGME49_232020-HA does not localise to the moving junction in invading parasites (Fig. 2C) . It was recently shown that RON9, RON10 and RON11, in contrast to the other RONs described to date, do not relocalise from the rhoptry neck to the moving junction during host invasion (Lamarque et al., 2012; Beck et al., 2013) . TGME49_232020 localisation also seems to be independent of the moving junction. Similar to TGME49_232020, RON10 has a predicted signal peptide in its N-terminus but no known domains or motifs have been identified. In contrast, RON9 harbors several protein-protein interaction domains. The disruption of either RON9 or RON10 led to the retention of either protein in the endoplasmic reticulum (ER), suggesting an interaction between RON9 and RON10 during their trafficking through the secretory pathway on the way to the rhoptries. Whether TGME49_232020 can interact with the RON9/RON10 complex or any other rhoptry neck protein in a similar fashion remains to be determined. TGME49_261740 co-localises with ROP1 ( Fig. 2B ) and is also found in the nucleus of infected host cells (Fig. 2D ). NLS Mapper (Kosugi et al., 2009 ) predicts that TGME49_261740 (ROP47) encodes a bipartite NLS with a score of 3.4. Moreover, this protein is predicted to have a size of 15 kDa and is probably able to diffuse through nuclear pores.
Altogether, these results suggest that TGME49_261740 and TGME49_218270 encode new rhoptry bulb proteins, hereafter referred to as ROP47 and ROP48, respectively. TGME49_232020 codes for a new rhoptry neck protein, from now on referred to as RON12.
TGME49_201860 and ROP48 are not implicated in evasion of the IFNc response
To investigate the role of TGME49_201860, ROP47 and ROP48 in parasite biology, we removed these genes in the PruDhxgprtDku80 strain using double homologous recombination. PCR confirmed both the absence of the target gene coding sequences and the insertion of the hxgprt gene in the parasite genome. The deletion of ROP47 was confirmed by western blot ( Supplementary  Fig. S1B ). Our attempts to generate a KO of RON12 in the PruDhxgprtDku80 strain have to date been unsuccessful.
To determine a potential growth phenotype, monolayers of MEF were infected with PruDhxgprtDku80, Dtgme49_201860 or Drop48 parasites, the parasites were allowed to grow for 5 days, and then the areas of the plaques formed on the monolayers were quantified Fig. 4 . Deletion of the genes encoding TGME49_201860, ROP47 and ROP48 does not affect Toxoplasma gondii virulence in mice. C57BL/6 mice were infected with 500 tachyzoites and weight and survival of mice was monitored. (A) Average percentage change in weight over time for mice i.p. infected with the indicated strains; n P 4 for each strain, mean + SD. (B) Mouse survival after i.p. infection with indicated strains; n P 4 for each strain. (C) IFNc cytokine levels in peripheral blood serum of surviving animals (n P 2 for each strain) was determined by ELISA at days 7 (D7) and 30 (D30) p.i., mean ± SD. Pru, PruDhxgprtDku80. Het, Heterologous control. (D) Average number of brain cysts at day 35 following i.p. infection with the indicated strains; n P 2 for each strain; mean ± SD. Pru -PruDhxgprtDku80. Het -Heterologous control.
⁄ P = 0.0011, Student's t-test. (Fig. 3A) . PruDhxgprtDku80, Dtgme49_201860 and Drop48 strains did not form significantly different sized plaques. These data indicate that deletion of TGME49_201860 or ROP48 has no major influence on in vitro Toxoplasma growth.
It is well established that IFNc is the main mediator of resistance against Toxoplasma (Suzuki et al., 1988 ). An important class of downstream effectors of this immune activation is the IFNcinducible immunity-related GTPases (IRGs), which belong to the dynamin family of GTPases and can cooperatively oligomerize to vesiculate membranes. The IRGs are able to disrupt the PVM and kill the parasite (Butcher et al., 2005) . Recently, two rhoptry proteins were shown to mediate Toxoplasma evasion of the IFNcÀinduced IRGs in murine cells (Fentress et al., 2010; Steinfeldt et al., 2010; Niedelman et al., 2012) . To study a potential role of ROP48 and TGME49_201860 in Toxoplasma resistance to IFNc and the IRGs, we measured the percentage of vacuoles coated with Irgb6 by IF in IFNc-stimulated MEFs infected with PruDhxgprtDku80, Dtgme49_201860 or Drop48. The percentage of coated vacuoles was approximately 50% in both Dtgme49_201860 and Drop48 and was not significantly different from that of the parental strain, PruDhxgprtDku80 (Fig. 3B) . Although it is generally assumed that once the PVM is coated, it will eventually lead to killing of the parasite inside, it has also been shown that Toxoplasma can escape a coated vacuole and invade a new cell (Zhao et al., 2009) . Therefore, to measure killing of Toxoplasma, a plaque loss assay was performed, as described in Niedelman et al. (2012) . Briefly, 100 parasites were seeded on a monolayer of MEF, either previously stimulated for 24 h with IFNc or left untreated, and the number of plaques that form after 5 days of growth was determined. The three strains had an average of $30% plaque loss when comparing plaques formed on IFNc-stimulated MEFs with unstimulated MEFs. This percentage of plaque loss was lower than the percentage of vacuoles coated with Irgb6, suggesting that some coated vacuoles can escape destruction by the IRGs. Overall, the results suggest that TGME49_201860 and ROP48 are not implicated in evading the IFNc response in MEFs. Indeed, ROP5 and ROP18 were recently reported to mediate Toxoplasma evasion of the murine IFNc response . These two proteins seem to determine the majority of strain differences in mouse IRG evasion, even for nonclonal strains for which virulence determinants have not been studied. However, neither ROP18 nor ROP5 markedly affect survival in IFNc-activated human cells and it is reasonable to speculate that one or more still unidentified, secreted, potentially a rhoptry, protein could be involved in escaping IFNc-mediated killing in other host cell types. Whether this (these) protein(s) can be found within the rhoptry cluster will be the object of future studies.
TGME49_201860, ROP47 and ROP48 are not implicated in Toxoplasma virulence in mice
To examine the role of TGME49_201860, ROP47 and ROP48 on parasite virulence, we infected C57BL/6 mice by i.p. injection with 500 tachyzoites of PruDhxgprtDku80, Dtgme49_201860, Drop47, Drop48 or a heterologous control strain (Het) and assessed mouse morbidity (through monitoring of weight loss) and survival during the initial phase of infection (days 0-32) (Fig. 4A, B) . Weight loss started at day 4 p.i. The mice reached their lowest weight between days 14 and 18 ($80% of their initial body weight) and did not regain their original weight. The survival of C57BL/6 mice infected with either strain did not show significant differences compared with PruDhxgprtDku80 infected mice (P = 0.9060, Log-rank Mantel-Cox test). Seroconversion was examined at day 30 p.i. and all the animals tested seropositive (data not shown). The level of IFNc in peripheral blood serum was measured at day 7 and day 30 p.i. (Fig. 4D) . IFNc levels were higher at day 7 than day 30 and similar for all the strains. Prior to infection, animals did not display detectable levels of IFNc. At day 35 p.i., the surviving mice were sacrificed and the number of brain cysts per mouse was determined (Fig. 4C) . The numbers of cysts generated by the Dtgme49_201860, Drop47 and Drop48 parasites were not significantly different from that of their parental strain. The number of brain cysts observed in the mice injected i.p. with the heterologous control strain was significantly lower ($1.6-fold, P = 0.0011, Student's t-test) than that observed in mice infected with PruDhxgprtDku80 parasites. Accordingly, it was previously reported that PruDku80::hxgprt exhibited lower cyst burdens than PruDhxgprtDku80 (Fox et al., 2011) , which suggests the presence of HXGPRT might affect generation or viability of brain cysts. Additionally, we infected C57BL/6 mice by oral gavage with 1000 brain cysts of the same strains. We found no difference in mouse morbidity and survival (data not shown).
Overall, the results suggest that TGME49_201860, ROP47 and ROP48 are not implicated in Toxoplasma virulence in mice. Interestingly, relatively few rhoptry proteins seem to have been investigated on their ability to affect virulence in the mouse model. Of the 10 proteins that were reported, ROP5, ROP16, ROP13, ROP18, RON8, RON9/10, TLN1, BRP1 and PP2C-hn (Saeij et al., 2006; Gilbert et al., 2007; Turetzky et al., 2010; Hajagos et al., 2011; Straub et al., 2011; Lamarque et al., 2012; Niedelman et al., 2012; ) , only four (RON8, ROP5, ROP16, ROP18) have an effect on mouse survival. However, mouse virulence is often tested in tachyzoites, the asexually reproducing form of the parasite, leaving out events that are restricted to the sexual life cycle of the parasite. Alternatively, the mouse model used may not be the optimal setting to reveal an essential role for such proteins in infection. For instance, a role in virulence could only be apparent in other intermediate hosts and/or when cysts are ingested naturally. Elucidation of this question will be extremely challenging due to the remarkable host range of Toxoplasma.
